NCT03518125View on ClinicalTrials.gov

BARDA Securing Anthrax Immunity For the Elderly

PHASE2CompletedINTERVENTIONAL
Enrollment

305

Participants

Timeline

Start Date

May 9, 2018

Primary Completion Date

January 14, 2019

Study Completion Date

December 9, 2019

Conditions
Anthrax
Interventions
BIOLOGICAL

BioThrax

"Other Names:~Anthrax Vaccine Adsorbed (AVA)"

BIOLOGICAL

AV7909

Anthrax Vaccine Absorbed plus CPG 7909 Adjuvant

DRUG

Sodium chloride injection USP, 0.9% (placebo)

"Other Names:~Saline Solution"

Trial Locations (4)

29464

Coastal Carolina Research Center, Mt. Pleasant

Clinical Research Associates, Inc., Nashville

66219

Johnson County Clin-Trials, Lenexa

84124

JBR Clinical Research, Salt Lake City

All Listed Sponsors
collaborator

Rho, Inc.

INDUSTRY

lead

Biomedical Advanced Research and Development Authority

FED

NCT03518125 - BARDA Securing Anthrax Immunity For the Elderly | Biotech Hunter | Biotech Hunter